Neonatal Bilirubin Forecasting via Dynamic Model Parameters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring neonatal hyperbilirubinemia rely on single bilirubin measurements, failing to account for dynamics and individual variability, leading to inaccuracies and difficulties in predicting future levels and optimizing phototherapy.
Innovation Solution
A method that acquires a series of bilirubin levels and covariates from neonates, using a bilirubin model function to estimate future bilirubin levels by determining model parameters, incorporating phototherapy effects, and accounting for inter- and intra-individual variability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If a single bilirubin measurement is used for monitoring, then the monitoring process is simple, but the accuracy of bilirubin level assessment deteriorates due to inter- and intra-individual variability
Solution Approach 1:
The patent transitions from static single-point bilirubin measurement to dynamic multi-point temporal monitoring. By acquiring bilirubin levels at multiple time points and analyzing the time course pattern, the system captures the dynamic behavior of bilirubin metabolism, thereby improving assessment accuracy while maintaining operational simplicity through automated analysis.
Solution Approach 2:
The patent implements feedback by using previously acquired bilirubin measurements to inform and improve subsequent assessments. The model uses the time course of bilirubin levels to predict future values and adjust monitoring strategies, creating a closed-loop system that continuously refines accuracy based on observed patterns.
2Measurement precision
If multiple bilirubin measurements over time are acquired, then the accuracy of bilirubin level forecasting improves, but the complexity of the monitoring system increases
Solution Approach 1:
The patent introduces a bilirubin model function as an intermediary that processes multiple measurements and covariates. This model acts as a mediator between raw data and clinical decisions, synthesizing temporal patterns and risk factors into coherent forecasts without requiring complex manual analysis, thus managing system complexity while improving accuracy.
Solution Approach 2:
The patent utilizes changes in model parameters over time to capture the evolving nature of bilirubin metabolism. By allowing parameters to vary temporally and in response to covariates, the system achieves high forecasting accuracy while keeping the underlying structure manageable through parameterized modeling rather than complex algorithms.
3Ease of operation
If a static bilirubin chart approach is used, then the method is easy to apply, but the ability to account for individual variability and dynamics deteriorates
Solution Approach 1:
The patent applies local quality by tailoring the bilirubin assessment to each individual neonate's specific characteristics and time course pattern. Instead of a uniform static chart, the model adapts to individual variability through personalized model parameters and covariate-specific adjustments, allowing each patient to be evaluated according to their unique metabolic profile while maintaining ease of application through automated processing.
Data Source
AI summary
The invention relates to a method and a computer program for estimating a bilirubin level of a neonate, composed of the steps of:Acquiring a series of bilirubin levels estimated at different time points from a sample obtained from a neonate,Acquiring a plurality of covariates from the neonate, each composed of an information about a neonatal property,Providing a pre-defined bilirubin model function, wherein the bilirubin model function is configured to describe a time course of a bilirubin level of a neonate,Determining a plurality of model parameters of the bilirubin model function, wherein each model parameter is estimated from at least one covariate of the plurality of covariates and an associated population model parameter,Determining from the series of acquired bilirubin levels and the bilirubin model function with the determined model parameters an expected bilirubin level of the neonate for a time particularly later than a lastly acquired bilirubin level of the series of bilirubin levels.